Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Beta adrenergic receptor stimulating agent"'
Autor:
Necip Atar, Mehmet Lütfi Yola
Publikováno v:
Materials Science and Engineering: C. 96:669-676
WOS: 000456760700070
30606580
beta-Agonists are illegally consumed in various products such as food and animal and effect the nutrition distribution owing to change of body fat. In addition, they result in acute poisoning and several sympto
30606580
beta-Agonists are illegally consumed in various products such as food and animal and effect the nutrition distribution owing to change of body fat. In addition, they result in acute poisoning and several sympto
Autor:
Yola, M.L., Atar, N.
β-Agonists are illegally consumed in various products such as food and animal and effect the nutrition distribution owing to change of body fat. In addition, they result in acute poisoning and several symptoms such as muscular tremors and nervousnes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::82a597d682d1937fd1d06f7bedc4b10a
Autor:
Claus Vogelmeier, Jaco Voorham, Leonardo M. Fabbri, Victoria Carter, Janwillem W. H. Kocks, David Price, Dave Singh, Marjan Kerkhof, Massimo Corradi, Alberto Papi
Publikováno v:
ERJ Open Research, 5(3). European Respiratory Society
ERJ Open Research
ERJ Open Research, Vol 5, Iss 3 (2019)
ERJ Open Research
ERJ Open Research, Vol 5, Iss 3 (2019)
This real-world study compared the effectiveness of triple therapy (TT; long-acting muscarinic antagonists (LAMAs)/long-acting inhaled β-agonists (LABAs)/inhaled corticosteroids (ICSs)) versus dual bronchodilation (DB; LAMAs/LABAs) among patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddcd21588867cedfe1cbe567bae43651
http://hdl.handle.net/11392/2407907
http://hdl.handle.net/11392/2407907
Autor:
Fernando C. Wehrmeister, Ana M. B. Menezes, Larissa Ramirez, Alejandro Casas, Maria Montes de Oca, Maria Victorina Lopez Varela, Laura Mendoza, Marc Miravitlles
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Vogelmeier, C.F., Criner, G.J., Martinez, F.J., Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary (2017) Am J Respir Crit Care Med, 195 (5), pp. 557-582
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Vogelmeier, C.F., Criner, G.J., Martinez, F.J., Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary (2017) Am J Respir Crit Care Med, 195 (5), pp. 557-582
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Alejandro Casas,1 Maria Montes de Oca,2 Ana MB Menezes,3 Fernando C Wehrmeister,3 Maria Victorina Lopez Varela,4 Laura Mendoza,5 Larissa Ramírez,6 Marc Miravitlles7 On behalf of the LASSYC team 1Fundación Neumológica Colombiana, Universidad del Ro
Autor:
Wan Yau Ming, S., Rhee, C.K., Park, H.Y., Yoo, K.H., Kim, D.K., Van Boven, J.F., Price, D., Park, H.S.
Publikováno v:
Respirology, 21:APSR6-0779. Wiley
Background and Aims: Historically, dry powder inhalers (DPIs) were considered to provide better airway distribution, easier identification of empty devices, and easier handling when compared to pressurized metered dose inhalers (pMDIs). Prior researc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::6ca369d5f08b630a8d412ec51cf0c697
https://research.rug.nl/en/publications/c3212c6e-92ed-46fc-849c-9693f5eb9d11
https://research.rug.nl/en/publications/c3212c6e-92ed-46fc-849c-9693f5eb9d11
Publikováno v:
Respirology. 21
Background and Aims: Historically, dry powder inhalers (DPIs) were considered to provide better airway distribution, easier identification of empty devices, and easier handling when compared to pressurized metered dose inhalers (pMDIs). Prior researc
Autor:
Mario Cazzola, Maria Gabriella Matera
Publikováno v:
Drugs. 67:503-515
There has been a real interest recently in developing once-daily beta(2)-adrenoceptor agonists (ultra-long-acting beta(2)-adrenoceptor agonists [ultra-LABAs]) for treating asthma and chronic obstructive pulmonary disease (COPD) in an attempt to simpl
Autor:
N. Van Hoof, A. Draaijer, Dirk Courtheyn, H.F. De Brabander, M.J. van Baak, P. Boshuis, K De Wasch, M Van de Wiele, R. Schilt, E. van der Vlis, J. Van Hende
Publikováno v:
Analytica Chimica Acta, 1-2 SPEC. ISS., 529, 189-197
Zilpaterol is a new powerful beta-agonist, which is officially registered for fattening purposes in cattle in Mexico and South Africa. Its chemical structure is different from the well-known beta-agonists. Therefore, the routinely used screening meth
Publikováno v:
Inflammation Research, 9, 48, 497-502
Objective and Design: To investigate the suppressive effects of the β-agonist clenbuterol on the release of TNF-α and IL-6 in a lipopolysaccharide (LPS)-model of inflammation, both in vitro and in vivo. Material and Subjects: Human U-937 cell line